Cite

MLA Citation

    R. Carlevato et al.. “PH-0499 SABR as a treatment option for HCC patients: efficacy and toxicity profile.” Radiotherapy and oncology, vol. 161, n.d., pp. S381–S382. http://access.bl.uk/ark:/81055/vdc_100144485930.0x000054
  
Back to record